RECODEX
GLP-051Retatrutide research vial

Triple Agonist Signal

Retatrutide

GLP-051 · 30 mg lyophilized

Retatrutide is cataloged in the RECODEX metabolic research library for GLP, incretin, and energy-balance pathway exploration. The supplied research size is 30mg. This listing is for qualified laboratory research use only and is not a dosing guide, protocol, or therapeutic claim.

Pathway
GIP, GLP-1, and glucagon receptor pharmacology
Code role
Triple-receptor research tool for advanced metabolic models.

$9.99

/ vial · 30 mg lyophilized

For Research Use Only · Not for human or veterinary use

Research overview

Mechanism notes

  • Retatrutide 30mg research SKU for incretin and metabolic-pathway studies.
  • Use this compound only in qualified, in-vitro research contexts.

Research use cases

Bench-scale models

  • Triple agonist research
  • Metabolic signaling
  • Glucagon pathway models

How it fits into stacks

Research stacks

Retatrutide appears in these research bundles. Stacks group adjacent signals for faster cart building in pre-clinical pathway studies.

Research references

Related

Retatrutide · GLP-051 — RECODEX